Olipass Corp

244460

Company Profile

  • Business description

    Olipass Corp is a South Korea based biotechnology company engaged in developing its platform OliPass PNA which focuses on introducing cationic lipid moiety onto nucleobase. Its pipeline products include SC Injection, Hyper Cholesterolemia, Chemo/Radio-sensitizer, and Type II Diabetes among others.

  • Contact

    16-4, 16 Beon-gil, Dongbaek Jungang-ro
    Ace Dongbaek Tower 20th Floor
    Giheung-gu
    Yongin17015
    KOR

    T: +82 3180608200

    https://www.olipass.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    27

Stocks News & Analysis

stocks

Solid start to fiscal 2026 for BHP

Production guidance is maintained by management.
stocks

Coca-Cola earnings: Innovation and brand strength underpin growth

We plan to raise our fair value estimate of Coca-Cola stock.
stocks

Going into earnings, is Netflix stock a buy, a sell, or fairly valued?

Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,390.1016.400.17%
CAC 408,258.8652.790.64%
DAX 4024,330.0371.230.29%
Dow JONES (US)46,983.28276.700.59%
FTSE 1009,426.9923.420.25%
HKSE26,027.55168.720.65%
NASDAQ22,973.0017.54-0.08%
Nikkei 22549,316.06130.560.27%
NZX 50 Index13,377.8532.890.25%
S&P 5006,742.377.240.11%
S&P/ASX 2009,094.7018.800.21%
SSE Composite Index3,916.3352.441.36%

Market Movers